#below-sidebar .right .fl{--wpr-bg-adc844aa-246d-42b7-be87-244ff9c8ca51: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .go{--wpr-bg-4369f727-554b-4165-bca0-98ef41ec6baa: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .fb{--wpr-bg-e11b6b37-d545-44ad-babf-48ed9d0dfc05: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .tw{--wpr-bg-b55d7fbc-488e-4d51-8f4d-ae51211e50ae: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.fl{--wpr-bg-cf8aba51-c236-439d-a1bf-080275143277: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.go{--wpr-bg-6d93ce58-36a2-4294-8ed0-5eb00a396e33: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.fb{--wpr-bg-bb0ab4ed-8b00-47f5-9794-36aaa6999df3: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.tw{--wpr-bg-893e6335-1f3a-4876-b5d6-7892ab38669b: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials .searchform{--wpr-bg-17797b74-b640-4fbb-aef2-a8c5a22e6040: url('https://www.nagpurtoday.in/wp-content/uploads/2021/08/serchbg-1.png');}.sbi_lb-loader span{--wpr-bg-11327ead-ec04-425c-be46-5f0a3471a232: url('https://www.nagpurtoday.in/wp-content/plugins/instagram-feed/img/sbi-sprite.png');}.sbi_lb-nav span{--wpr-bg-fa6614c5-4c15-4e9d-9597-3bb52ee690a4: url('https://www.nagpurtoday.in/wp-content/plugins/instagram-feed/img/sbi-sprite.png');}

Home » Covid vaccine in open mkt by year end: Guleria

Published On : Wed, Feb 17th, 2021

By Nagpur Today

Covid vaccine in open mkt by year end: Guleria

Watch Live News

AIIMS Director Dr Randeep Guleria receives the second dose of the COVID-19 vaccine shot. “Vaccine will be available in open market only when prime targets — people to be vaccinated — are covered and there’s equivalence of supply-demand. Hopefully there’d be such situation by year-end or before that. Then there would be likelihood of vaccine to come to open market,” Dr Guleria said.